Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.
D000293:Adolescent; D000328:Adult; D000380:Agranulocytosis / Q000150:complications*; D000666:Amphotericin B / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005335:Fever of Unknown Origin / Q000209:etiology*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D009181:Mycoses / Q000188:drug therapy; D009369:Neoplasms / Q000150:complications*; D011446:Prospective Studies; D011897:Random Allocation
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D005839:Gentamicins; D000666:Amphotericin B; D002228:Carbenicillin; D002512:Cephalothin